These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37309076)

  • 1. Clinical outcomes of oral anticoagulant discontinuation in atrial fibrillation: a systematic review and meta-analysis.
    Kefale AT; Bezabhe WM; Peterson GM
    Expert Rev Clin Pharmacol; 2023; 16(7):677-684. PubMed ID: 37309076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis.
    Kuno T; Takagi H; Ando T; Sugiyama T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Briasoulis A; Burger A; Bangalore S
    J Am Coll Cardiol; 2020 Jan; 75(3):273-285. PubMed ID: 31976865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. It can be safe to discontinue oral anticoagulants after successful atrial fibrillation ablation: A systematic review and meta-analysis of cohort studies.
    Wang X; Li M; Wang X; Zhang Z
    Medicine (Baltimore); 2023 Oct; 102(42):e35518. PubMed ID: 37861532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Clin Res Cardiol; 2022 Jan; 111(1):23-33. PubMed ID: 33704551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.
    Lee MY; Han S; Bang OY; On YK; Jang SW; Han S; Ryu J; Park YJ; Kang S; Suh HS; Kim YH
    Adv Ther; 2022 Jul; 39(7):3112-3130. PubMed ID: 35524839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Anticoagulant Agents in Patients With Atrial Fibrillation and CKD: A Systematic Review and Pairwise Network Meta-analysis.
    Su X; Yan B; Wang L; Lv J; Cheng H; Chen Y
    Am J Kidney Dis; 2021 Nov; 78(5):678-689.e1. PubMed ID: 33872690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan　- Findings From the AF Frontier Ablation Registry.
    Okumura Y; Nagashima K; Arai M; Watanabe R; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Shimizu W; Iwasaki YK; Hayashi H; Harada T; Nakajima I; Okumura K; Koyama J; Tokuda M; Yamane T; Momiyama Y; Tanimoto K; Soejima K; Nonoguchi N; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Satomi K; Yazaki Y; Watari Y;
    Circ J; 2019 Nov; 83(12):2418-2427. PubMed ID: 31619591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis.
    Proietti M; Romiti GF; Romanazzi I; Farcomeni A; Staerk L; Nielsen PB; Lip GYH
    Int J Cardiol; 2018 Jun; 261():84-91. PubMed ID: 29572080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation.
    Kim D; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
    Stroke; 2022 Jun; 53(6):1873-1882. PubMed ID: 35109686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic and Bleeding Outcomes in Patients With Atrial Fibrillation and Contraindications to Oral Anticoagulation.
    Steinberg BA; Ballew NG; Greiner MA; Lippmann SJ; Curtis LH; O'Brien EC; Patel MR; Piccini JP
    JACC Clin Electrophysiol; 2019 Dec; 5(12):1384-1392. PubMed ID: 31857036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis.
    Shakir A; Khan A; Agarwal S; Clifton S; Reese J; Munir MB; Nasir UB; Khan SU; Gopinathannair R; DeSimone CV; Deshmukh A; Jackman WM; Stavrakis S; Asad ZUA
    J Interv Card Electrophysiol; 2023 Mar; 66(2):493-506. PubMed ID: 36085242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA.
    Dhamane AD; Hernandez I; Di Fusco M; Gutierrez C; Ferri M; Russ C; Tsai WL; Emir B; Yuce H; Keshishian A
    Am J Cardiovasc Drugs; 2022 May; 22(3):333-343. PubMed ID: 34671944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis.
    Harrison SL; Buckley BJR; Ritchie LA; Proietti R; Underhill P; Lane DA; Lip GYH
    J Am Geriatr Soc; 2022 Aug; 70(8):2386-2392. PubMed ID: 35587227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
    O'Brien EC; Holmes DN; Thomas LE; Fonarow GC; Allen LA; Gersh BJ; Kowey PR; Singer DE; Ezekowitz MD; Naccarelli GV; Ansell JE; Chan PS; Mahaffey KW; Go AS; Freeman JV; Reiffel JA; Peterson ED; Piccini JP; Hylek EM
    Circulation; 2018 Aug; 138(9):889-897. PubMed ID: 29678813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF Registry.
    Cools F; Johnson D; Camm AJ; Bassand JP; Verheugt FWA; Yang S; Tsiatis A; Fitzmaurice DA; Goldhaber SZ; Kayani G; Goto S; Haas S; Misselwitz F; Turpie AGG; Fox KAA; Pieper KS; Kakkar AK;
    J Thromb Haemost; 2021 Sep; 19(9):2322-2334. PubMed ID: 34060704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients.
    Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Marín F
    Thromb Haemost; 2017 Jun; 117(7):1448-1454. PubMed ID: 28331926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of anticoagulant-related bleeding events with cancer detection in atrial fibrillation: A systematic review and meta-analysis.
    Papanastasiou A; Morsi-Yeroyannis A; Karagiannidis E; Kartas A; Doundoulakis I; Karvounis H; Giannakoulas G
    Hellenic J Cardiol; 2021; 62(5):359-365. PubMed ID: 33242617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis.
    Grymonprez M; Steurbaut S; De Sutter A; Lahousse L
    Open Heart; 2020 Dec; 7(2):. PubMed ID: 33361315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.